]> C60.0 Prepuce C60.1 Glans penis C60.2 Body of penis C60.8 Overlapping lesion of penis C60.9 Penis, NOS Note 1: This schema is NOT used for Malignant Melanoma, Merkel Cell Carcinoma of Penis, Kaposi Sarcoma, Mycosis Fungoides, Sezary Disease, or Other Lymphomas. Each of these diseases has a separate schema. Note 2: Primary carcinoma of the urethra is to be coded C68.0 and assigned Collaborative Stage codes according to the urethra schema. &generalsize; CS Extension Note 1: Over 90% of penile cancers are squamous cell carcinomas arising in the skin. Other cancers arising in the skin include adenocarcinomas (5%) arising in sweat glands, melanomas (2%, included in the melanoma schema), and basal cell carcinoma (2%). About 1% of penile cancers are sarcomas, arising in subcutaneous connective tissues. Note 2: Verrucous carcinoma (M-8051) is a locally aggressive, exophytic, low grade carcinoma with minimal metastatic potential. Note 3: If verrucous carcinoma is described as noninvasive or as having a broad pushing border or penetration, assign code 050. If verrucous carcinoma is not so characterized, assign code 070, Verrucous carcinoma, NOS. If there is destructive invasion of verrucous carcinoma into structures in code 100 or greater, assign the appropriate higher code. Note 4: Information about involvement of the corpus spongiosum or corpus cavernosum is collected in this field for anatomic staging. This information is also collected in CS Site-Specific Factor 1 because involvement of these structures may have an independent effect on prognosis. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 Tis Tis IS IS 050 Ta Ta IS IS 070 Ta Ta L L 100 ^ T1 L L 300 Localized, NOS ^ T1 L L 305 Satellite nodules on prepuce or glans ^ T1 RE RE 310 Stated as T1a with no other information on extension ^ T1 L L 320 Stated as T1b with no other information on extension ^ T1 L L 350 T2 T2 L L 360 T2 T2 RE RE 400 T2 T2 RE RE 460 400 + 305 T2 T2 RE RE 500 ERROR ERROR ERROR ERROR 550 T2 T2 RE RE 560 Stated as T2 with no other information on extension T2 T2 L L 600 ERROR T3 RE RE 620 T3 T3 RE RE 650 Prostate T4 T3 RE RE 700 T4 T4 RE RE 800 T4 T4 D D 810 Stated as T4 with no other information on extension T4 T4 RE RE 950 No evidence of primary tumor T0 T0 U U 999 TX TX U U ^ For CS Extension codes 100-320 ONLY, the T category is assigned based on Grade and Lymph-vascular Invasion, as shown in the Extension Grade LVI Table for this schema. &generalcstsexteval; CS Lymph Nodes Note 1: Code only regional nodes and nodes, NOS, in this field. Distant nodes are coded in the field Mets at DX. Code Description TNM 7 Map TNM 6 Map SS77 Map SS2000 Map 000 No regional lymph node involvement N0 N0 NONE NONE 100 ^ N1 RN RN 200 ^ N2 RN RN 250 ^ N1 RN RN 260 ^ N1 RN RN 270 ^ N2 RN RN 300 ERROR N3 RN RN 310 ^ N3 RN RN 350 ^ N3 RN RN 370 ^ N1 RN RN 380 ^ N1 RN RN 400 N3 N3 RN RN 450 Stated as N3 with no other information on regional lymph nodes N3 N3 RN RN 500 ^ N1 RN RN 505 ^ N1 RN RN 800 Lymph nodes, NOS N1 N1 RN RN 999 NX NX U U ^ For CS Lymph nodes codes 100-270, 310-380, 500 and 505 ONLY, the N category for AJCC 7 staging is assigned based on the value of CS Site-Specific Factor 17, Extranodal Extension of Regional Lymph Nodes, as shown in the Lymph Node Extranodal Extension table for this schema. &generalregnodeseval; &generalreglnpos; &generalreglnexam; &commonmetsatdxscrotum; &generalmetseval; ¬appssfactor1; ¬appssfactor2; ¬appssfactor3; ¬appssfactor4; ¬appssfactor5; ¬appssfactor6; ¬appnewssf7; ¬appnewssf8; ¬appnewssf9; CS Site-Specific Factor 10 Involvement of Corpus Spongiosum/Corpus Cavernosum Note 1: Information about involvement of the corpus spongiosum and corpus cavernosum is collected in CS Extension as an element in anatomic staging. This information is also collected in this field as it may have an independent effect on prognosis. Note 2: Record the involvement of the corpus spongiosum and corpus cavernosum as documented in the pathology report. Assign code 000 if surgical resection of the primary site is performed and includes corpus spongiosum and/or corpus cavernosum, the pathology report is available for review, and corpus spongiosum and/or corpus cavernosum involvement is not mentioned. If surgical resection of the primary site is performed without corpus spongiosum and/or corpus cavernosum included in the specimen, assign code 998. Code Description 000 Involvement of corpus spongiosum and/or corpus cavernosum not present/not identified 010 Involvement of corpus spongiosum only 020 Involvement of corpus cavernosum only 030 988 998 999 CS Site-Specific Factor 11 Poorly Differentiated Tumor Percentage Note 1: Record the exact percentage of the primary tumor that is poorly differentiated as documented in the pathology report. Note 2: For values greater than zero and less than 1%, round to 001. For codes 001 to 100, round values to the nearest percent. Code Description 000 Poorly differentiated tumor not present/not identified 001-100 988 990 998 No histologic examination of primary site 999 CS Site-Specific Factor 12 Human Papilloma Virus (HPV) Status Note 1: There is evidence that HPV plays a role in the pathogenesis of some cancers. HPV testing may be performed for prognostic purposes; testing may also be performed on metastatic sites to aid in determination of the primary site. Note 2: Record the results of any HPV testing performed on pathologic specimens from the primary tumor or a metastatic site, including lymph nodes. Do not record the results of blood tests or serology. Note 3: HPVs are divided into high-risk and low-risk types. The highest risk HPV types are types 16 and 18. Other high-risk types are 26, 31, 33, 35, 36, 45, 51, 52, 53, 56, 58, 59, 66, 67, 68, 69, 70, 73, 82, and 85. The HPV vaccine is designed to protect against types 16 and 18 (associated with cervical cancer) and types 6 and 11 (associated with genital warts). Low-risk types are 6, 11, 32, 34, 40, 42, 44, 54, 61, 62, 64, 71, 72, 74, 81, 83, 84, 87, and 89. Note 4: High-risk may be abbreviated hrHPV or HR-HPV. Note 5: Some tests for HPV, such as a hybrid capture test, may only report negative or positive results for high-risk HPV without identifying types. Use codes 000 or 060, respectively, to report those test results. Note 6: Codes 010-050 are hierarchical; use the highest code that applies. Code Description 000 010 HPV positive for low-risk types only 020 030 040 050 060 HPV positive for high-risk type(s), NOS, high-risk type(s) not stated 070 HPV positive, NOS, risk and type(s) not stated 988 997 Test ordered, results not in chart 998 Test not done (test not ordered and not performed) No pathologic specimen available for HPV testing 999 ¬appnewssf13; ¬appnewssf14; ¬appnewssf15; &commonssf16penis; CS Site-Specific Factor 17 Extranodal Extension of Regional Lymph Nodes Note 1: Code the status of extranodal extension whether assessed clinically or pathologically of any involved regional lymph node(s) coded in CS Lymph Nodes. Do not code extranodal extension for any nodes coded in CS Mets at DX. Note 2: A statement of the presence or absence of extranodal extension in a pathology report takes priority over clinical assessment. Note 3: If nodes are involved but the clinical documentation and/or pathologic documentation does not indicate extranodal extension, assign code 010 (no extranodal extension documented on available reports). Note 4: If the only documentation is a reference to clinically or pathologically involved nodes with no reference to extranodal extension, assign code 030 (no physical examination/imaging report and/or no pathology report available). Code Description 000 No regional lymph nodes involved 010 020 030 Regional nodes involved, unknown if extranodal extension 988 999 ¬appnewssf18; ¬appnewssf19; ¬appnewssf20; ¬appnewssf21; ¬appnewssf22; ¬appnewssf23; ¬appnewssf24; ¬appnewssf25; &commonhistinclusioncarcinomanonmerkel; &commonhistologyexclusions1; AJCC TNM 7 Stage T N M Stage T0 N0 M0 ERROR T0 N1 M0 IIIA T0 N2 M0 IIIB T0 N3 M0 IV T0 NX M0 UNK Ta N0 M0 0 Ta N1 M0 ERROR Ta N2 M0 ERROR Ta N3 M0 ERROR Ta NX M0 0 Tis N0 M0 0 Tis N1 M0 ERROR Tis N2 M0 ERROR Tis N3 M0 ERROR Tis NX M0 0 T1a N0 M0 I T1a N1 M0 IIIA T1a N2 M0 IIIB T1a N3 M0 IV T1a NX M0 UNK T1b N0 M0 II T1b N1 M0 IIIA T1b N2 M0 IIIB T1b N3 M0 IV T1b NX M0 UNK T1NOS N0 M0 I T1NOS N1 M0 IIIA T1NOS N2 M0 IIIB T1NOS N3 M0 IV T1NOS NX M0 UNK T2 N0 M0 II T2 N1 M0 IIIA T2 N2 M0 IIIB T2 N3 M0 IV T2 NX M0 UNK T3 N0 M0 II T3 N1 M0 IIIA T3 N2 M0 IIIB T3 N3 M0 IV T3 NX M0 UNK T4 N0 M0 IV T4 N1 M0 IV T4 N2 M0 IV T4 N3 M0 IV T4 NX M0 IV TX N0 M0 UNK TX N1 M0 UNK TX N2 M0 UNK TX N3 M0 IV TX NX M0 UNK T0 N0 M1 IV T0 N1 M1 IV T0 N2 M1 IV T0 N3 M1 IV T0 NX M1 IV Ta N0 M1 ERROR Ta N1 M1 ERROR Ta N2 M1 ERROR Ta N3 M1 ERROR Ta NX M1 ERROR Tis N0 M1 ERROR Tis N1 M1 ERROR Tis N2 M1 ERROR Tis N3 M1 ERROR Tis NX M1 ERROR T1a N0 M1 IV T1a N1 M1 IV T1a N2 M1 IV T1a N3 M1 IV T1a NX M1 IV T1b N0 M1 IV T1b N1 M1 IV T1b N2 M1 IV T1b N3 M1 IV T1b NX M1 IV T1NOS N0 M1 IV T1NOS N1 M1 IV T1NOS N2 M1 IV T1NOS N3 M1 IV T1NOS NX M1 IV T2 N0 M1 IV T2 N1 M1 IV T2 N2 M1 IV T2 N3 M1 IV T2 NX M1 IV T3 N0 M1 IV T3 N1 M1 IV T3 N2 M1 IV T3 N3 M1 IV T3 NX M1 IV T4 N0 M1 IV T4 N1 M1 IV T4 N2 M1 IV T4 N3 M1 IV T4 NX M1 IV TX N0 M1 IV TX N1 M1 IV TX N2 M1 IV TX N3 M1 IV TX NX M1 IV &commonstagepenis; &commonsummarystage; Extension Grade LVI Table Note: For CS Extension codes 100, 300, 310, 320 and 500 ONLY, the AJCC 7th Edition T category is assigned based on the value of Grade and Lymph-vascular Invasion as shown in this table. CS Extension Grade Lymph-vascular Invasion T Category 100 1-2 0 T1a 100 1-2 1 T1b 100 1-2 8-9 T1NOS 100 3-4 0 T1b 100 3-4 1 T1b 100 3-4 8-9 T1b 100 9 0 T1NOS 100 9 1 T1b 100 9 8-9 T1NOS 300 1-2 0 T1a 300 1-2 1 T1b 300 1-2 8-9 T1NOS 300 3-4 0 T1b 300 3-4 1 T1b 300 3-4 8-9 T1b 300 9 0 T1NOS 300 9 1 T1b 300 9 8-9 T1NOS 305 1-2 0 T1a 305 1-2 1 T1b 305 1-2 8-9 T1NOS 305 3-4 0 T1b 305 3-4 1 T1b 305 3-4 8-9 T1b 305 9 0 T1NOS 305 9 1 T1b 305 9 8-9 T1NOS 310 1-2 0 T1a 310 1-2 1 T1b 310 1-2 8-9 T1a 310 3-4 0 T1b 310 3-4 1 T1b 310 3-4 8-9 T1b 310 9 0 T1a 310 9 1 T1b 310 9 8-9 T1a 320 1-2 0 T1a 320 1-2 1 T1b 320 1-2 8-9 T1b 320 3-4 0 T1b 320 3-4 1 T1b 320 3-4 8-9 T1b 320 9 0 T1b 320 9 1 T1b 320 9 8-9 T1b Lymph Node Extranodal Extension Table Note: For CS Lymph Nodes codes 100-270, 310-380, 500 and 505 ONLY, the N category for AJCC 7 staging is assigned based on the value of CS Site-Specific Factor 17, Extranodal Extension of Regional Lymph Nodes, as shown in this table. CS Lymph Nodes SSF17 000 0 SSF17 010 10 SSF17 020 20 SSF17 030 30 SSF17 988-999 988 999 100 ERROR N1 N3 N1 N1 200 ERROR N2 N3 N2 N2 250 ERROR N1 N3 N1 N1 260 ERROR N1 N3 N1 N1 270 ERROR N2 N3 N2 N2 310 ERROR N1 N3 N1 N1 350 ERROR N2 N3 N2 N2 370 ERROR N1 N3 N1 N1 380 ERROR N1 N3 N1 N1 500 ERROR N1 N3 N1 N1 505 ERROR N1 N3 N1 N1